Devyser Q2 - Delivering well on its financial targets
2022-08-29 08:27:00
Redeye is once again positively surprised by the strong gross margin (80% Act. vs. 77% REe) and sees Q2 sales in line with our estimates. We are enthusiastic about the company’s commercial progression and emphasize that Devyser is already delivering on two of its three financial targets. We reiterate our SEK 120 Base Case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/